title: Far beyond informed consent. US research institutions keep close watch on OPRR's suspensions.
authors.forename: M
authors.initials: M
authors.lastname: Russell-Einhorn
authors.forename: J
authors.initials: J
authors.lastname: Vaitukaitis
authors.forename: R
authors.initials: R
authors.lastname: Snyderman
authors.forename: A
authors.initials: A
authors.lastname: Rubenstein
authors.forename: R
authors.initials: R
authors.lastname: Abramson
authors.forename: M
authors.initials: M
authors.lastname: Hays
authors.forename: L
authors.initials: L
authors.lastname: Goodman
mesh_terms: D002985:Clinical Protocols / Q000592:standards*; D002986:Clinical Trials as Topic / Q000592:standards*; D006805:Human Experimentation / Q000331:legislation & jurisprudence*; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D009316:National Institutes of Health (U.S.) / Q000331:legislation & jurisprudence*; D014481:United States